TRIM21 and neonatal lupus erythematosus: The aim of this study was twofold; first, to determine whether antibodies to the Ro52 peptide 365–382 are important in predicting a complication in pregnant women with Ro antibodies; and, second, to identify other putative Ro52 epitopes associated with neonatal lupus and CHB.